pipette
ENEnglish

HDAC1/2 maintain TERT mRNA stability in TERT-rearranged neuroblastoma

S. Finkler, A. Szymansky, A. Annika Spruessel, S. Castelli, C. Gatzweiler, F. Schulze, J. F. Hollander, R. Chamorro Gonzalez, K. Hauptmann, S. Fuchs, K. Helmsauer, A. Eggert, D. Beule, A. Kuehl, M. Lodrini, A. G. Henssen, N. Bluethgen, J. Weiner, H. E. Deubzer

PreprintUso en el mundo real

En palabras de los autores

Genomic TERT locus rearrangements define an aggressive high-risk neuroblastoma subgroup characterized by enhancer hijacking, high-level TERT expression and continuous telomerase activation. Although these structural alterations supply a strong transcriptional drive, the post-transcriptional mechanisms preserving TERT mRNA presence remain incompletely understood. We identified histone deacetylases 1 and 2 (HDAC1/2) as essential post-transcriptional guardians of TERT mRNA stability in TERT-rearranged neuroblastoma. Pharmacological inhibition or RNAi-mediated depletion of HDAC1 and HDAC2, but not HDACs 3-11, rapidly downregulated TERT transcript levels and suppressed telomerase enzymatic activity. Transcript decay kinetics following transcriptional arrest with actinomycin D confirmed that HDAC1/2 blockade accelerates TERT mRNA decay, reducing transcript half-life by 30-47%. High-resolution ChIP-seq profiling across the translocation breakpoint demonstrated HDAC inhibition does not alter local chromatin accessibility. Array-based DNA methylation profiling showed only a mild, non-specific global reduction in CpG island methylation upon panobinostat exposure and no focal correlation with TERT transcript loss across the breakpoint locus. Depleting TERT mRNA via HDAC1/2 inhibition dismantled a core 50-gene TERT-associated oncogenic expression network. Ectopic re-expression of TERT cDNA partially rescued cellular viability and normalized expression of key signature genes despite continuous HDAC inhibition. HDAC1/2 inhibition significantly attenuated tumor growth, reduced intratumor TERT expression and prolonging overall survival in both preventive and therapeutic TERT-rearranged xenograft mouse models. Our data establish a post-transcriptional rather than transcriptional mode of TERT regulation and confirm tumor suppression is partly driven by depleting TERT transcripts, uncovering a HDAC1/2 dependency in TERT-driven neuroblastoma. We provide a molecular rationale for therapeutic strategies disrupting HDAC1/2-mediated TERT mRNA stabilization.

Resultado principalEl resumen no menciona limitaciones.

Apareció: miércoles, 18 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.11.15.766789